Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-024225-20Phase 2Completed
Phase 2, open-label, single-arm trial of sodium glycerophosphate, sponsored by LMU Klinikum. Primary endpoint: Weak acids concentration (A-). Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-024225-20.